Asthma

In an abstract presenting during the ATS conference, investigators find infants with asthma are surprisingly older on the epigentic clock.

New findings from ATS show the residual effects of vaping-associated lung distress.

The lead PATHWAY investigator explains the intent and outcomes from the most recent phase 2B findings.

A discussion with a study author on promising new findings for the combination inhaler therapy.

A new assessment shows risk reduction is even more significant among COPD patients who have smoked.

Treatment drug results in a significant reduction in severe exacerbations for patients with eosinophil ≥150 cells/µL.

A 52-week assessment shows patients of varying interleukin serum levels equally benefitted from the TSLP inhibitor.

New trial testing vitamin D supplementation in pediatric asthma patients was stopped early because of ineffective data.

New ATS findings show the IL-5 inhibitor has sustained and oftentimes improved benefit in patients from 6 months to 12.

Dr. Ian Pavord discusses new meta-analyses of dupilumab planned for ATS 2020 on the DocTalk podcast.

Patients with the splice variant were significantly less likely to have raised blood eosinophil counts.